IMRIS neurosurgical HFD rocker arm receives FDA clearance

MINNEAPOLIS, Sept. 11, 2014 - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced a new rocker arm accessory that expands choices for neurosurgeons to select the best fixation suited for patients during procedures using intraoperative imaging inside the VISIUS Surgical Theatre. The accessory recently received 510(k) clearance from the U.S. Food and Drug Administration.

The new rocker arm accessory provides more flexibility for the surgeon to stabilize, support and position patient heads with varying cranial anatomy, sizes and conditions using the MRI-compatible IMRIS HFD. When attached to the head fixation device (HFD) - a clamp-like device - the rocker arm helps to reduce the pressure on the individual contact points on the patient's skull.

Misonix, Inc. Announces Fourth Quarter and Fiscal Year End 2014 Financial Results

Fourth Quarter Net Revenues UP 48%;
BoneScalpel™Revenue UP 65%; SonaStar® Revenue up 75%; Fiscal Year Revenue Increased 15%;
Net Income of $1.4 million or $0.19 per Diluted Share

FARMINGDALE, N.Y., Sept. 10, 2014 -- Misonix, Inc. (MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today announced financial results for the fourth quarter and full year fiscal 2014 ended June 30, 2014.

National Government Services Issues Positive Coverage for Percutaneous Tibial Nerve Stimulation

MINNEAPOLIS, Aug. 11, 2014 -- Uroplasty, Inc. (UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that National Government Services (NGS) has issued a positive coverage decision for Posterior Tibial Nerve Stimulation (PTNS) for the treatment of urinary urgency, urinary frequency and urge incontinence associated with overactive bladder (OAB).  Coverage for the proprietary Urgent PC® device was effective August 10, 2014.

NGS, a Medicare Administrative Contractor, provides medical and drug benefits to approximately 10 million Medicare beneficiaries in the states of New York, Illinois, Massachusetts, Wisconsin, Minnesota, Connecticut, Maine, New Hampshire, Rhode Island and Vermont.

Hansen Medical Announces US Commercial Availability of Magellan(TM) Transport System

MOUNTAIN VIEW, CA--( Aug 27, 2014) - Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it has received U.S. Food and Drug Administration 510(k) clearance for a modified rail for the Magellan™ Robotic System, which enables the company to begin commercial introduction of the Magellan™ Transport System. The Magellan Transport System is designed to move the Magellan robotic arm between procedure rooms. The Company anticipates commercialization of the Magellan Transport System in the third quarter of fiscal 2014.

Alpha Pro Tech, Ltd. Announces Financial Results for the Second Quarter Ended June 30, 2014

Consolidated Sales Increased 10% to $12.3 Million in Second Quarter
Income from Operations Increased 48% for the Second Quarter to $1.03 Million

NOGALES, Ariz.-- Alpha Pro Tech, Ltd.:

  • Disposable Protective Apparel segment sales for the three months ended June 30, 2014, increased 24.2% to $3.8 million, compared to $3.1 million for the same period of 2013.
  • Selling, general and administrative expenses decreased to 26.9% of sales for the quarter ended June 30, 2014, compared to 28.5% for the quarter ended June 30, 2013.
  • Net income increased 88.8% to $895,000 for the quarter ended June 30, 2014, compared to $474,000 for the quarter ended June 30, 2013.
  • Basic and diluted earnings per common share for the quarters ended June 30, 2014 and 2013 were $0.05 and $0.02, respectively.